摘要
目的:探讨糖尿病患者白内障超声乳化(phacoemulsification,PHACO)联合人工晶体(IOL)植入术的临床疗效。方法:对97例(106眼)糖尿病患者和99例(109眼)非糖尿病患者的PHACO联合IOL植入术疗效进行比较。结果:两组术后并发症的发生率比较,差异无统计学意义,糖尿病患者有49只眼(46.23%)术后矫正视力达0.5以上,而非糖尿病患者有64只眼(59.26%)术后矫正视力达0.5以上,两者比较差异也无统计学意义(P>0.05)。结论:对于糖尿病患者,只要术前经过适当饮食控制或加用适量降糖药物,使血糖稳定在一定水平而无全身或眼部严重并发症者,施行PHACO联合IOL植入术是安全可靠的。对增殖性视网膜病变的糖尿病患者,仍应视为手术禁忌证。
Objective：To analyse effect of phacoemulsification（PHACO） and intraocular lens（IOL） implantation on treating patients with diabetes mellilus.Methods：PHACO and IOL implantation were performed on 97（106 eyes） diabetics and 99（109 eyes） nondiabetics patients.The therapeutic effect was compared.Results：There was no significant difference in incidence of postoperative complications.The postoperative corrected visual acuities of 0.5 or better were achieved in 49（46.23%） of diabetic eyes and in 64（59.26%）of nondiabetic eyes（P〉0.05）.Conclusions：For diabetics patients with cataract,who are under control by diet or hypoglycemic agent,and have stable blood glucose level for a period of time without other systemic and ocular complications,PHACO and IOL implantation is safe and reliable treatment.But proliferative retinopathy is contraindicative for this treatment
出处
《海南医学院学报》
CAS
2011年第1期123-125,共3页
Journal of Hainan Medical University
基金
海南医学院科研基金资助学报项目(0020110025)~~
关键词
白内障摘除术
糖尿病
人工晶状体植入术
眼疾病
Phacoemulsification
Diabetes mellitus
Intraocular lens implantation
Eye disease
